At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
TEM Tempus AI
Market Closed 02-13 16:00:00 EST
51.95
+1.17
+2.30%
盘后52.46
+0.51+0.98%
19:59 EST
High52.65Low50.43Vol3.14M
Open51.04D1 Closing50.78Amplitude4.37%
Mkt Cap9.24BTradable Cap5.28BTotal Shares177.91M
T/O162.55MT/O Rate3.09%Tradable Shares101.68M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Tempus AI Inc. Reports Acquisition of Personalis Inc. Common Shares
Reuters  ·  02-14 06:25
Tempus AI Inc. Reports Acquisition of Personalis Inc. Common Shares
Cathie Wood's Ark Scoops Up $12.4 Million In Beaten-Down Robinhood — Dumps More Airbnb Shares
Benzinga  ·  02-13 13:00
Cathie Wood's Ark Scoops Up $12.4 Million In Beaten-Down Robinhood — Dumps More Airbnb Shares
Tempus AI Partners with Median Technologies to Integrate AI Lung Cancer Screening
Reuters  ·  02-13 05:08
Tempus AI Partners with Median Technologies to Integrate AI Lung Cancer Screening
Tempus Announces Collaboration With Median Technologies to Integrate AI-Powered Lung Cancer Screening Into the Pixel Platform
THOMSON REUTERS  ·  02-13 05:05
Tempus Announces Collaboration With Median Technologies to Integrate AI-Powered Lung Cancer Screening Into the Pixel Platform
AI Software Shares Tumbled. AppLovin Down 16%; Unity Down 7%; BigBear.Ai, Roblox And Shopify Down 5%; Spotify, Tempus And SoundHound Down 4%
Tiger Newspress  ·  02-12
AI Software Shares Tumbled. AppLovin Down 16%; Unity Down 7%; BigBear.Ai, Roblox And Shopify Down 5%; Spotify, Tempus And SoundHound Down 4%
AI Software Shares Tumbled. Unity Down 33%; Duolingo Down 6%; HubSpot, Figma, Shopify, SoundHound And GitLab Down 5%; Rubrik, AppLovin, C3.Ai And Datadog Down 4%
Tiger Newspress  ·  02-11
AI Software Shares Tumbled. Unity Down 33%; Duolingo Down 6%; HubSpot, Figma, Shopify, SoundHound And GitLab Down 5%; Rubrik, AppLovin, C3.Ai And Datadog Down 4%
Press Release: Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
Dow Jones  ·  02-10
Press Release: Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
AI Software Shares Kept Rally. Spotify And Datadog Up 10%; Shopify Up 5%; Unity, AppLovin And MongoDB Up 3%; Palantir And Cloudflare Up 2%
Tiger Newspress  ·  02-10
AI Software Shares Kept Rally. Spotify And Datadog Up 10%; Shopify Up 5%; Unity, AppLovin And MongoDB Up 3%; Palantir And Cloudflare Up 2%
24H | Some AI Software Shares Jump With AppLovin up over 4%, Shopify up over 3%; Silver Stocks & ETFs Fall With AGQ Down over 5%, SLV Down About 3%
Tiger Newspress  ·  02-10
24H | Some AI Software Shares Jump With AppLovin up over 4%, Shopify up over 3%; Silver Stocks & ETFs Fall With AGQ Down over 5%, SLV Down About 3%
AI Application Shares Rebounded. Roblox And AppLovin Up 8%; Unity Up 6%; MongoDB Up 4%; Palantir And Shopify Up 2%
Tiger Newspress  ·  02-09
AI Application Shares Rebounded. Roblox And AppLovin Up 8%; Unity Up 6%; MongoDB Up 4%; Palantir And Shopify Up 2%
Premarket Movers | Space Stocks Rally With Virgin Galactic up over 8%; AI Application Software Shares Gain With AppLovin up over 5%, Palantir up over 2%
Tiger Newspress  ·  02-09
Premarket Movers | Space Stocks Rally With Virgin Galactic up over 8%; AI Application Software Shares Gain With AppLovin up over 5%, Palantir up over 2%
Tempus AI-Tochter Ambry Genetics unterstützt bahnbrechende Forschung zu Krebsgenen
Reuters  ·  02-04
Tempus AI-Tochter Ambry Genetics unterstützt bahnbrechende Forschung zu Krebsgenen
What's Going On With Tempus AI Stock Monday?
Benzinga_recent_news  ·  02-02
What's Going On With Tempus AI Stock Monday?
Ambry Genetics Hits One Million RNA-Enhanced Genetic Tests Under Tempus AI
Reuters  ·  02-02
Ambry Genetics Hits One Million RNA-Enhanced Genetic Tests Under Tempus AI
Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares
Reuters  ·  01-31
Tempus AI CEO Eric Lefkofsky Reports Sale of Common Shares
Assessing Tempus AI (TEM) Valuation After New Immune Profile Score Breakthrough
Simply Wall St.  ·  01-30
Assessing Tempus AI (TEM) Valuation After New Immune Profile Score Breakthrough
Form 144 | Tempus AI's Officer Eric Lefkofsky proposes to sell 166,250 Shares, with a total value of approximately $11.1 Million.
Filings Track  ·  01-29
Form 144 | Tempus AI's Officer Eric Lefkofsky proposes to sell 166,250 Shares, with a total value of approximately $11.1 Million.
Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits
MT Newswires Live  ·  01-27
Tempus Says Study Shows AI-Driven Test More Accurately Predicts Immunotherapy Benefits
Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide
TIPRANKS  ·  01-27
Cathie Wood Sells Biotech Stocks, Bets Big on Tempus AI and WeRide
Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors
Benzinga_recent_news  ·  01-27
Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors
No data available

Introduction

Company Name.
Tempus AI
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a strategic collaborations agreement with AstraZeneca and Pathos AI, Inc. to develop therapeutic programs in oncology. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Issue price:
--